Akston Biosciences Corp

CIK 1776612 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akston Biosciences Corp.

Recent SEC filings

FiledFormAccession number
May 4, 2026FWP0001104659-26-054483
May 4, 2026S-1/A0001104659-26-054475
Apr 10, 2026FWP0001104659-26-041995
Apr 10, 2026S-1/A0001104659-26-041980
Feb 18, 2026FWP0001104659-26-017033
Feb 18, 2026S-1/A0001104659-26-017032
Jan 15, 2026FWP0001104659-26-004162
Jan 15, 2026S-1/A0001104659-26-004158
Dec 8, 2025S-1/A0001104659-25-119211
Nov 17, 2025S-1/A0001104659-25-112780
Oct 8, 2025S-10001104659-25-097958
Apr 15, 2022D0001776612-22-000001
Jun 9, 2021D/A0001776612-21-000002
Jun 1, 2021D0001776612-21-000001
Dec 30, 2020D0001776612-20-000002
May 12, 2020D0001776612-20-000001
Jun 20, 2019D0001776612-19-000001